Cell Line and Membrane Market By Products (Media and Reagents, Equipments, Accessories and Consumables), By Source (Non Mammalian Cell Line, Mammalian Cell Line), By Type (Recombinant cell lines, Primary cell lines, Hybridomas, Continuous cell lines), By End User (Biotechnology and Pharmaceutical Industries, Academic and Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global cell line and membrane market was valued at $4,533.04 million in 2021, and is projected to reach $10,574.56 million by 2031, registering a CAGR of 8.8% from 2022 to 2031.A cell line is a permanently established cell culture that will multiply indefinitely in a given appropriate fresh medium and space and is frequently used to investigate biological processes in place of primary cells. Transfection, selection, and single-cell cloning are all a part of the cell line generation process. Various types of cells are used to create different cell lines. Cell lines allow for the gradual changes in cell structure, physiology, and genetic makeup in a controlled setting. . Cell lines are derived from single cells and are used to make fusion proteins, monoclonal antibodies, and vaccines.
Cell lines have revolutionized scientific research and they are widely used in the production of vaccine, testing drug metabolism & cytotoxicity, antibody production, study of gene function, generation of artificial tissues (artificial skin), and synthesis of biological compounds (therapeutic proteins).
The key factors that drive the growth of market are rise in the prevalence of cancer & chronic diseases, rise in geriatric population, and increase in number of vaccine production. In addition, the rise in novel drug development activities, growth in use of mammalian cell for cell line production, and surge in technological advancements in expression vector design are the key factors that boost the market growth. For instance, according to the International Agency of Cancer Research, 9,503,710 new cancer cases were diagnosed in Asia in 2020.
However, the strict regulatory framework coupled with the time-consuming process for the development of stable lines hampers the market growth. Conversely, emerging healthcare market in developing countries & low-income countries and increase in the risk of pandemic & communicable diseases are expected to provide lucrative opportunity for the growth of market during the forecast period.
The cell line and membrane market is segmented on the basis of product, source, type, end user, and region. By product, the market is fragmented into media & reagents, equipment, accessories, and consumables. By source, it is bifurcated into mammalian cell line and non-mammalian cell line. On the basis of type, the market is categorized into recombinant cell type, hybridomas, continuous cell line and primary cell line. By end user, the market is divided into biotech companies, academic and research institutes and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
North America accounted for a majority of the cell line and membrane market share in 2021 and is anticipated to remain dominant during the forecast period owing to rise in the prevalence of cancer, increased use of media & reagents for cell line development, and presence of major key players in the region.
Asia-Pacific was the second largest contributor to the market in 2021, and is expected to register the fastest CAGR during the forecast period, owing to rise in prevalence of chronic diseases and increase in geriatric population in developing countries.
The key players that operate in the cell line and membrane market are Advanced Instruments LLC, AGC Biologics, Cytiva Lifesciences, Sartorius Cellgenix Gmbh, Premas Biotech, Selexis SA, Lonza, Samsung Biologics, PromoCell, Thermofisher Scientific Inc, Imegenex India Pvt. Ltd., and ProBioGen
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cell line and membrane market analysis from 2021 to 2031 to identify the prevailing cell line and membrane market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the cell line and membrane market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global cell line and membrane market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Products
Media and Reagents
Type
Serum
Media
Reagents
Equipments
Type
Biosafety Cabinets
Cell Counters and Viability Systems
Incubators
Centrifuges
Bioreactors
Storage Equipment
Others
Accessories and Consumables
By Source
Non Mammalian Cell Line
Type
Insects
Amphibians
Mammalian Cell Line
By Type
Hybridomas
Continuous cell lines
Recombinant cell lines
Primary cell lines
By End User
Biotechnology and Pharmaceutical Industries
Academic and Research Institutes
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest Of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest Of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest Of LAMEA
Key Market Players
Advanced Instruments LLC
AGC Biologics
Cytiva Lifesciences
Sartorius
Cellgenix Gmbh
Premas Biotech
Selexis SA
Samsung Biologics
Lonza
Thermofisher Scientific Inc
PromoCell
ProBioGen
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: CELL LINE AND MEMBRANE MARKET, BY PRODUCTS
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Media and Reagents
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Media and Reagents Cell Line and Membrane Market by Type
- 4.2.4.1 Serum Market size and forecast, by region
- 4.2.4.2 Media Market size and forecast, by region
- 4.2.4.3 Reagents Market size and forecast, by region
- 4.3 Equipments
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Equipments Cell Line and Membrane Market by Type
- 4.3.4.1 Biosafety Cabinets Market size and forecast, by region
- 4.3.4.2 Cell Counters and Viability Systems Market size and forecast, by region
- 4.3.4.3 Incubators Market size and forecast, by region
- 4.3.4.4 Centrifuges Market size and forecast, by region
- 4.3.4.5 Bioreactors Market size and forecast, by region
- 4.3.4.6 Storage Equipment Market size and forecast, by region
- 4.3.4.7 Others Market size and forecast, by region
- 4.4 Accessories and Consumables
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
- CHAPTER 5: CELL LINE AND MEMBRANE MARKET, BY SOURCE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Non Mammalian Cell Line
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.2.4 Non Mammalian Cell Line Cell Line and Membrane Market by Type
- 5.2.4.1 Insects Market size and forecast, by region
- 5.2.4.2 Amphibians Market size and forecast, by region
- 5.3 Mammalian Cell Line
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- CHAPTER 6: CELL LINE AND MEMBRANE MARKET, BY TYPE
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Recombinant cell lines
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Primary cell lines
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Hybridomas
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- 6.5 Continuous cell lines
- 6.5.1 Key market trends, growth factors and opportunities
- 6.5.2 Market size and forecast, by region
- 6.5.3 Market analysis by country
- CHAPTER 7: CELL LINE AND MEMBRANE MARKET, BY END USER
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 Biotechnology and Pharmaceutical Industries
- 7.2.1 Key market trends, growth factors and opportunities
- 7.2.2 Market size and forecast, by region
- 7.2.3 Market analysis by country
- 7.3 Academic and Research Institutes
- 7.3.1 Key market trends, growth factors and opportunities
- 7.3.2 Market size and forecast, by region
- 7.3.3 Market analysis by country
- 7.4 Others
- 7.4.1 Key market trends, growth factors and opportunities
- 7.4.2 Market size and forecast, by region
- 7.4.3 Market analysis by country
- CHAPTER 8: CELL LINE AND MEMBRANE MARKET, BY REGION
- 8.1 Overview
- 8.1.1 Market size and forecast
- 8.2 North America
- 8.2.1 Key trends and opportunities
- 8.2.2 North America Market size and forecast, by Products
- 8.2.2.1 North America Media and Reagents Cell Line and Membrane Market by Type
- 8.2.2.2 North America Equipments Cell Line and Membrane Market by Type
- 8.2.3 North America Market size and forecast, by Source
- 8.2.3.1 North America Non Mammalian Cell Line Cell Line and Membrane Market by Type
- 8.2.4 North America Market size and forecast, by Type
- 8.2.5 North America Market size and forecast, by End User
- 8.2.6 North America Market size and forecast, by country
- 8.2.6.1 U.S.
- 8.2.6.1.1 Market size and forecast, by Products
- 8.2.6.1.2 Market size and forecast, by Source
- 8.2.6.1.3 Market size and forecast, by Type
- 8.2.6.1.4 Market size and forecast, by End User
- 8.2.6.2 Canada
- 8.2.6.2.1 Market size and forecast, by Products
- 8.2.6.2.2 Market size and forecast, by Source
- 8.2.6.2.3 Market size and forecast, by Type
- 8.2.6.2.4 Market size and forecast, by End User
- 8.2.6.3 Mexico
- 8.2.6.3.1 Market size and forecast, by Products
- 8.2.6.3.2 Market size and forecast, by Source
- 8.2.6.3.3 Market size and forecast, by Type
- 8.2.6.3.4 Market size and forecast, by End User
- 8.3 Europe
- 8.3.1 Key trends and opportunities
- 8.3.2 Europe Market size and forecast, by Products
- 8.3.2.1 Europe Media and Reagents Cell Line and Membrane Market by Type
- 8.3.2.2 Europe Equipments Cell Line and Membrane Market by Type
- 8.3.3 Europe Market size and forecast, by Source
- 8.3.3.1 Europe Non Mammalian Cell Line Cell Line and Membrane Market by Type
- 8.3.4 Europe Market size and forecast, by Type
- 8.3.5 Europe Market size and forecast, by End User
- 8.3.6 Europe Market size and forecast, by country
- 8.3.6.1 Germany
- 8.3.6.1.1 Market size and forecast, by Products
- 8.3.6.1.2 Market size and forecast, by Source
- 8.3.6.1.3 Market size and forecast, by Type
- 8.3.6.1.4 Market size and forecast, by End User
- 8.3.6.2 France
- 8.3.6.2.1 Market size and forecast, by Products
- 8.3.6.2.2 Market size and forecast, by Source
- 8.3.6.2.3 Market size and forecast, by Type
- 8.3.6.2.4 Market size and forecast, by End User
- 8.3.6.3 UK
- 8.3.6.3.1 Market size and forecast, by Products
- 8.3.6.3.2 Market size and forecast, by Source
- 8.3.6.3.3 Market size and forecast, by Type
- 8.3.6.3.4 Market size and forecast, by End User
- 8.3.6.4 Italy
- 8.3.6.4.1 Market size and forecast, by Products
- 8.3.6.4.2 Market size and forecast, by Source
- 8.3.6.4.3 Market size and forecast, by Type
- 8.3.6.4.4 Market size and forecast, by End User
- 8.3.6.5 Spain
- 8.3.6.5.1 Market size and forecast, by Products
- 8.3.6.5.2 Market size and forecast, by Source
- 8.3.6.5.3 Market size and forecast, by Type
- 8.3.6.5.4 Market size and forecast, by End User
- 8.3.6.6 Rest of Europe
- 8.3.6.6.1 Market size and forecast, by Products
- 8.3.6.6.2 Market size and forecast, by Source
- 8.3.6.6.3 Market size and forecast, by Type
- 8.3.6.6.4 Market size and forecast, by End User
- 8.4 Asia-Pacific
- 8.4.1 Key trends and opportunities
- 8.4.2 Asia-Pacific Market size and forecast, by Products
- 8.4.2.1 Asia-Pacific Media and Reagents Cell Line and Membrane Market by Type
- 8.4.2.2 Asia-Pacific Equipments Cell Line and Membrane Market by Type
- 8.4.3 Asia-Pacific Market size and forecast, by Source
- 8.4.3.1 Asia-Pacific Non Mammalian Cell Line Cell Line and Membrane Market by Type
- 8.4.4 Asia-Pacific Market size and forecast, by Type
- 8.4.5 Asia-Pacific Market size and forecast, by End User
- 8.4.6 Asia-Pacific Market size and forecast, by country
- 8.4.6.1 Japan
- 8.4.6.1.1 Market size and forecast, by Products
- 8.4.6.1.2 Market size and forecast, by Source
- 8.4.6.1.3 Market size and forecast, by Type
- 8.4.6.1.4 Market size and forecast, by End User
- 8.4.6.2 China
- 8.4.6.2.1 Market size and forecast, by Products
- 8.4.6.2.2 Market size and forecast, by Source
- 8.4.6.2.3 Market size and forecast, by Type
- 8.4.6.2.4 Market size and forecast, by End User
- 8.4.6.3 Australia
- 8.4.6.3.1 Market size and forecast, by Products
- 8.4.6.3.2 Market size and forecast, by Source
- 8.4.6.3.3 Market size and forecast, by Type
- 8.4.6.3.4 Market size and forecast, by End User
- 8.4.6.4 India
- 8.4.6.4.1 Market size and forecast, by Products
- 8.4.6.4.2 Market size and forecast, by Source
- 8.4.6.4.3 Market size and forecast, by Type
- 8.4.6.4.4 Market size and forecast, by End User
- 8.4.6.5 South Korea
- 8.4.6.5.1 Market size and forecast, by Products
- 8.4.6.5.2 Market size and forecast, by Source
- 8.4.6.5.3 Market size and forecast, by Type
- 8.4.6.5.4 Market size and forecast, by End User
- 8.4.6.6 Rest of Asia-Pacific
- 8.4.6.6.1 Market size and forecast, by Products
- 8.4.6.6.2 Market size and forecast, by Source
- 8.4.6.6.3 Market size and forecast, by Type
- 8.4.6.6.4 Market size and forecast, by End User
- 8.5 LAMEA
- 8.5.1 Key trends and opportunities
- 8.5.2 LAMEA Market size and forecast, by Products
- 8.5.2.1 LAMEA Media and Reagents Cell Line and Membrane Market by Type
- 8.5.2.2 LAMEA Equipments Cell Line and Membrane Market by Type
- 8.5.3 LAMEA Market size and forecast, by Source
- 8.5.3.1 LAMEA Non Mammalian Cell Line Cell Line and Membrane Market by Type
- 8.5.4 LAMEA Market size and forecast, by Type
- 8.5.5 LAMEA Market size and forecast, by End User
- 8.5.6 LAMEA Market size and forecast, by country
- 8.5.6.1 Brazil
- 8.5.6.1.1 Market size and forecast, by Products
- 8.5.6.1.2 Market size and forecast, by Source
- 8.5.6.1.3 Market size and forecast, by Type
- 8.5.6.1.4 Market size and forecast, by End User
- 8.5.6.2 Saudi Arabia
- 8.5.6.2.1 Market size and forecast, by Products
- 8.5.6.2.2 Market size and forecast, by Source
- 8.5.6.2.3 Market size and forecast, by Type
- 8.5.6.2.4 Market size and forecast, by End User
- 8.5.6.3 South Africa
- 8.5.6.3.1 Market size and forecast, by Products
- 8.5.6.3.2 Market size and forecast, by Source
- 8.5.6.3.3 Market size and forecast, by Type
- 8.5.6.3.4 Market size and forecast, by End User
- 8.5.6.4 Rest of LAMEA
- 8.5.6.4.1 Market size and forecast, by Products
- 8.5.6.4.2 Market size and forecast, by Source
- 8.5.6.4.3 Market size and forecast, by Type
- 8.5.6.4.4 Market size and forecast, by End User
- CHAPTER 9: COMPANY LANDSCAPE
- 9.1. Introduction
- 9.2. Top winning strategies
- 9.3. Product Mapping of Top 10 Player
- 9.4. Competitive Dashboard
- 9.5. Competitive Heatmap
- 9.6. Key developments
- CHAPTER 10: COMPANY PROFILES
- 10.1 Advanced Instruments LLC
- 10.1.1 Company overview
- 10.1.2 Company snapshot
- 10.1.3 Operating business segments
- 10.1.4 Product portfolio
- 10.1.5 Business performance
- 10.1.6 Key strategic moves and developments
- 10.2 AGC Biologics
- 10.2.1 Company overview
- 10.2.2 Company snapshot
- 10.2.3 Operating business segments
- 10.2.4 Product portfolio
- 10.2.5 Business performance
- 10.2.6 Key strategic moves and developments
- 10.3 Cytiva Lifesciences
- 10.3.1 Company overview
- 10.3.2 Company snapshot
- 10.3.3 Operating business segments
- 10.3.4 Product portfolio
- 10.3.5 Business performance
- 10.3.6 Key strategic moves and developments
- 10.4 Sartorius
- 10.4.1 Company overview
- 10.4.2 Company snapshot
- 10.4.3 Operating business segments
- 10.4.4 Product portfolio
- 10.4.5 Business performance
- 10.4.6 Key strategic moves and developments
- 10.5 Cellgenix Gmbh
- 10.5.1 Company overview
- 10.5.2 Company snapshot
- 10.5.3 Operating business segments
- 10.5.4 Product portfolio
- 10.5.5 Business performance
- 10.5.6 Key strategic moves and developments
- 10.6 Premas Biotech
- 10.6.1 Company overview
- 10.6.2 Company snapshot
- 10.6.3 Operating business segments
- 10.6.4 Product portfolio
- 10.6.5 Business performance
- 10.6.6 Key strategic moves and developments
- 10.7 Selexis SA
- 10.7.1 Company overview
- 10.7.2 Company snapshot
- 10.7.3 Operating business segments
- 10.7.4 Product portfolio
- 10.7.5 Business performance
- 10.7.6 Key strategic moves and developments
- 10.8 Samsung Biologics
- 10.8.1 Company overview
- 10.8.2 Company snapshot
- 10.8.3 Operating business segments
- 10.8.4 Product portfolio
- 10.8.5 Business performance
- 10.8.6 Key strategic moves and developments
- 10.9 Lonza
- 10.9.1 Company overview
- 10.9.2 Company snapshot
- 10.9.3 Operating business segments
- 10.9.4 Product portfolio
- 10.9.5 Business performance
- 10.9.6 Key strategic moves and developments
- 10.10 Thermofisher Scientific Inc
- 10.10.1 Company overview
- 10.10.2 Company snapshot
- 10.10.3 Operating business segments
- 10.10.4 Product portfolio
- 10.10.5 Business performance
- 10.10.6 Key strategic moves and developments
- 10.11 PromoCell
- 10.11.1 Company overview
- 10.11.2 Company snapshot
- 10.11.3 Operating business segments
- 10.11.4 Product portfolio
- 10.11.5 Business performance
- 10.11.6 Key strategic moves and developments
- 10.12 ProBioGen
- 10.12.1 Company overview
- 10.12.2 Company snapshot
- 10.12.3 Operating business segments
- 10.12.4 Product portfolio
- 10.12.5 Business performance
- 10.12.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 2. CELL LINE AND MEMBRANE MARKET, FOR MEDIA AND REAGENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. CELL LINE AND MEMBRANE MARKET FOR MEDIA AND REAGENTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. GLOBAL MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 5. CELL LINE AND MEMBRANE MARKET, FOR SERUM, BY REGION, 2021-2031 ($MILLION)
- TABLE 6. CELL LINE AND MEMBRANE MARKET, FOR MEDIA, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. CELL LINE AND MEMBRANE MARKET, FOR REAGENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. CELL LINE AND MEMBRANE MARKET, FOR EQUIPMENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 9. CELL LINE AND MEMBRANE MARKET FOR EQUIPMENTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 10. GLOBAL EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 11. CELL LINE AND MEMBRANE MARKET, FOR BIOSAFETY CABINETS, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. CELL LINE AND MEMBRANE MARKET, FOR CELL COUNTERS AND VIABILITY SYSTEMS, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. CELL LINE AND MEMBRANE MARKET, FOR INCUBATORS, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. CELL LINE AND MEMBRANE MARKET, FOR CENTRIFUGES, BY REGION, 2021-2031 ($MILLION)
- TABLE 15. CELL LINE AND MEMBRANE MARKET, FOR BIOREACTORS, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. CELL LINE AND MEMBRANE MARKET, FOR STORAGE EQUIPMENT, BY REGION, 2021-2031 ($MILLION)
- TABLE 17. CELL LINE AND MEMBRANE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 18. CELL LINE AND MEMBRANE MARKET, FOR ACCESSORIES AND CONSUMABLES, BY REGION, 2021-2031 ($MILLION)
- TABLE 19. CELL LINE AND MEMBRANE MARKET FOR ACCESSORIES AND CONSUMABLES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 20. GLOBAL CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 21. CELL LINE AND MEMBRANE MARKET, FOR NON MAMMALIAN CELL LINE, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. CELL LINE AND MEMBRANE MARKET FOR NON MAMMALIAN CELL LINE, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. GLOBAL NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 24. CELL LINE AND MEMBRANE MARKET, FOR INSECTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 25. CELL LINE AND MEMBRANE MARKET, FOR AMPHIBIANS, BY REGION, 2021-2031 ($MILLION)
- TABLE 26. CELL LINE AND MEMBRANE MARKET, FOR MAMMALIAN CELL LINE, BY REGION, 2021-2031 ($MILLION)
- TABLE 27. CELL LINE AND MEMBRANE MARKET FOR MAMMALIAN CELL LINE, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. GLOBAL CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 29. CELL LINE AND MEMBRANE MARKET, FOR RECOMBINANT CELL LINES, BY REGION, 2021-2031 ($MILLION)
- TABLE 30. CELL LINE AND MEMBRANE MARKET FOR RECOMBINANT CELL LINES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 31. CELL LINE AND MEMBRANE MARKET, FOR PRIMARY CELL LINES, BY REGION, 2021-2031 ($MILLION)
- TABLE 32. CELL LINE AND MEMBRANE MARKET FOR PRIMARY CELL LINES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 33. CELL LINE AND MEMBRANE MARKET, FOR HYBRIDOMAS, BY REGION, 2021-2031 ($MILLION)
- TABLE 34. CELL LINE AND MEMBRANE MARKET FOR HYBRIDOMAS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 35. CELL LINE AND MEMBRANE MARKET, FOR CONTINUOUS CELL LINES, BY REGION, 2021-2031 ($MILLION)
- TABLE 36. CELL LINE AND MEMBRANE MARKET FOR CONTINUOUS CELL LINES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 37. GLOBAL CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 38. CELL LINE AND MEMBRANE MARKET, FOR BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES, BY REGION, 2021-2031 ($MILLION)
- TABLE 39. CELL LINE AND MEMBRANE MARKET FOR BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRIES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 40. CELL LINE AND MEMBRANE MARKET, FOR ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2021-2031 ($MILLION)
- TABLE 41. CELL LINE AND MEMBRANE MARKET FOR ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 42. CELL LINE AND MEMBRANE MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 43. CELL LINE AND MEMBRANE MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 44. CELL LINE AND MEMBRANE MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 45. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 46. NORTH AMERICA MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 47. NORTH AMERICA EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 48. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 49. NORTH AMERICA NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 50. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 51. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 52. NORTH AMERICA CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 53. U.S. CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 54. U.S. CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 55. U.S. CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 56. U.S. CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 57. CANADA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 58. CANADA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 59. CANADA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 60. CANADA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 61. MEXICO CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 62. MEXICO CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 63. MEXICO CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 64. MEXICO CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 65. EUROPE CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 66. EUROPE MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 67. EUROPE EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 68. EUROPE CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 69. EUROPE NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 70. EUROPE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 71. EUROPE CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 72. EUROPE CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 73. GERMANY CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 74. GERMANY CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 75. GERMANY CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 76. GERMANY CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 77. FRANCE CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 78. FRANCE CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 79. FRANCE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 80. FRANCE CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 81. UK CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 82. UK CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 83. UK CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 84. UK CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 85. ITALY CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 86. ITALY CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 87. ITALY CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 88. ITALY CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 89. SPAIN CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 90. SPAIN CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 91. SPAIN CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 92. SPAIN CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 93. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 94. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 95. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 96. REST OF EUROPE CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 97. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 98. ASIA-PACIFIC MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 99. ASIA-PACIFIC EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 100. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 101. ASIA-PACIFIC NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 102. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 103. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 104. ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 105. JAPAN CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 106. JAPAN CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 107. JAPAN CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 108. JAPAN CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 109. CHINA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 110. CHINA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 111. CHINA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 112. CHINA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 113. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 114. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 115. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 116. AUSTRALIA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 117. INDIA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 118. INDIA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 119. INDIA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 120. INDIA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 121. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 122. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 123. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 124. SOUTH KOREA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 125. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 126. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 127. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 128. REST OF ASIA-PACIFIC CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 129. LAMEA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 130. LAMEA MEDIA AND REAGENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 131. LAMEA EQUIPMENTS CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 132. LAMEA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 133. LAMEA NON MAMMALIAN CELL LINE CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 134. LAMEA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 135. LAMEA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 136. LAMEA CELL LINE AND MEMBRANE MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 137. BRAZIL CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 138. BRAZIL CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 139. BRAZIL CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 140. BRAZIL CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 141. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 142. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 143. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 144. SAUDI ARABIA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 145. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 146. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 147. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 148. SOUTH AFRICA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 149. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY PRODUCTS, 2021-2031 ($MILLION)
- TABLE 150. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY SOURCE, 2021-2031 ($MILLION)
- TABLE 151. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 152. REST OF LAMEA CELL LINE AND MEMBRANE MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 153.ADVANCED INSTRUMENTS LLC: COMPANY SNAPSHOT
- TABLE 154.ADVANCED INSTRUMENTS LLC: OPERATING SEGMENTS
- TABLE 155.ADVANCED INSTRUMENTS LLC: PRODUCT PORTFOLIO
- TABLE 156.ADVANCED INSTRUMENTS LLC: NET SALES,
- TABLE 157.ADVANCED INSTRUMENTS LLC: KEY STRATERGIES
- TABLE 158.AGC BIOLOGICS: COMPANY SNAPSHOT
- TABLE 159.AGC BIOLOGICS: OPERATING SEGMENTS
- TABLE 160.AGC BIOLOGICS: PRODUCT PORTFOLIO
- TABLE 161.AGC BIOLOGICS: NET SALES,
- TABLE 162.AGC BIOLOGICS: KEY STRATERGIES
- TABLE 163.CYTIVA LIFESCIENCES: COMPANY SNAPSHOT
- TABLE 164.CYTIVA LIFESCIENCES: OPERATING SEGMENTS
- TABLE 165.CYTIVA LIFESCIENCES: PRODUCT PORTFOLIO
- TABLE 166.CYTIVA LIFESCIENCES: NET SALES,
- TABLE 167.CYTIVA LIFESCIENCES: KEY STRATERGIES
- TABLE 168.SARTORIUS: COMPANY SNAPSHOT
- TABLE 169.SARTORIUS: OPERATING SEGMENTS
- TABLE 170.SARTORIUS: PRODUCT PORTFOLIO
- TABLE 171.SARTORIUS: NET SALES,
- TABLE 172.SARTORIUS: KEY STRATERGIES
- TABLE 173.CELLGENIX GMBH: COMPANY SNAPSHOT
- TABLE 174.CELLGENIX GMBH: OPERATING SEGMENTS
- TABLE 175.CELLGENIX GMBH: PRODUCT PORTFOLIO
- TABLE 176.CELLGENIX GMBH: NET SALES,
- TABLE 177.CELLGENIX GMBH: KEY STRATERGIES
- TABLE 178.PREMAS BIOTECH: COMPANY SNAPSHOT
- TABLE 179.PREMAS BIOTECH: OPERATING SEGMENTS
- TABLE 180.PREMAS BIOTECH: PRODUCT PORTFOLIO
- TABLE 181.PREMAS BIOTECH: NET SALES,
- TABLE 182.PREMAS BIOTECH: KEY STRATERGIES
- TABLE 183.SELEXIS SA: COMPANY SNAPSHOT
- TABLE 184.SELEXIS SA: OPERATING SEGMENTS
- TABLE 185.SELEXIS SA: PRODUCT PORTFOLIO
- TABLE 186.SELEXIS SA: NET SALES,
- TABLE 187.SELEXIS SA: KEY STRATERGIES
- TABLE 188.SAMSUNG BIOLOGICS: COMPANY SNAPSHOT
- TABLE 189.SAMSUNG BIOLOGICS: OPERATING SEGMENTS
- TABLE 190.SAMSUNG BIOLOGICS: PRODUCT PORTFOLIO
- TABLE 191.SAMSUNG BIOLOGICS: NET SALES,
- TABLE 192.SAMSUNG BIOLOGICS: KEY STRATERGIES
- TABLE 193.LONZA: COMPANY SNAPSHOT
- TABLE 194.LONZA: OPERATING SEGMENTS
- TABLE 195.LONZA: PRODUCT PORTFOLIO
- TABLE 196.LONZA: NET SALES,
- TABLE 197.LONZA: KEY STRATERGIES
- TABLE 198.THERMOFISHER SCIENTIFIC INC: COMPANY SNAPSHOT
- TABLE 199.THERMOFISHER SCIENTIFIC INC: OPERATING SEGMENTS
- TABLE 200.THERMOFISHER SCIENTIFIC INC: PRODUCT PORTFOLIO
- TABLE 201.THERMOFISHER SCIENTIFIC INC: NET SALES,
- TABLE 202.THERMOFISHER SCIENTIFIC INC: KEY STRATERGIES
- TABLE 203.PROMOCELL: COMPANY SNAPSHOT
- TABLE 204.PROMOCELL: OPERATING SEGMENTS
- TABLE 205.PROMOCELL: PRODUCT PORTFOLIO
- TABLE 206.PROMOCELL: NET SALES,
- TABLE 207.PROMOCELL: KEY STRATERGIES
- TABLE 208.PROBIOGEN: COMPANY SNAPSHOT
- TABLE 209.PROBIOGEN: OPERATING SEGMENTS
- TABLE 210.PROBIOGEN: PRODUCT PORTFOLIO
- TABLE 211.PROBIOGEN: NET SALES,
- TABLE 212.PROBIOGEN: KEY STRATERGIES
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook